GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (FRA:PSYB) » Definitions » FCF Yield %

PsyBio Therapeutics (FRA:PSYB) FCF Yield % : -94.43 (As of May. 29, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PsyBio Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, PsyBio Therapeutics's Trailing 12-Month Free Cash Flow is €-0.89 Mil, and Market Cap is €0.06 Mil. Therefore, PsyBio Therapeutics's FCF Yield % for today is -94.43%.

The historical rank and industry rank for PsyBio Therapeutics's FCF Yield % or its related term are showing as below:

FRA:PSYB' s FCF Yield % Range Over the Past 10 Years
Min: -1296.95   Med: 0   Max: 0
Current: -94.43


FRA:PSYB's FCF Yield % is ranked worse than
85.24% of 1551 companies
in the Biotechnology industry
Industry Median: -14.28 vs FRA:PSYB: -94.43

PsyBio Therapeutics's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.


PsyBio Therapeutics FCF Yield % Historical Data

The historical data trend for PsyBio Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PsyBio Therapeutics FCF Yield % Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
FCF Yield %
-33.41 -114.30

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -62.44 -23.35 -22.12 -32.55 131.31

Competitive Comparison of PsyBio Therapeutics's FCF Yield %

For the Biotechnology subindustry, PsyBio Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PsyBio Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PsyBio Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where PsyBio Therapeutics's FCF Yield % falls into.



PsyBio Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

PsyBio Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3.245 / 2.839119
=-114.30%

PsyBio Therapeutics's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0.314 * 4 / 0.9565425
=131.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PsyBio Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


PsyBio Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of PsyBio Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


PsyBio Therapeutics (FRA:PSYB) Business Description

Traded in Other Exchanges
Address
4400 Sample Road, Suite 138, Coconut Creek, FL, USA, 33073
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

PsyBio Therapeutics (FRA:PSYB) Headlines

No Headlines